Loomis, Sayles & Company’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-76,195
| Closed | -$2.41M | – | 986 |
|
|
2022
Q1 | $2.41M | Sell |
76,195
-4,827
| -6% | -$135K | ﹤0.01% | 426 |
|
|
2021
Q4 | $1.81M | Sell |
81,022
-2,269
| -3% | -$59.2K | ﹤0.01% | 469 |
|
|
2021
Q3 | $2.31M | Buy |
83,291
+769
| +0.9% | +$23.4K | ﹤0.01% | 440 |
|
|
2021
Q2 | $3.21M | Buy |
82,522
+1,655
| +2% | +$59.3K | ﹤0.01% | 428 |
|
|
2021
Q1 | $2.33M | Buy |
80,867
+10,863
| +16% | +$371K | ﹤0.01% | 440 |
|
|
2020
Q4 | $1.86M | Buy |
70,004
+3,356
| +5% | +$68.5K | ﹤0.01% | 447 |
|
|
2020
Q3 | $1.02M | Sell |
66,648
-882
| -1% | -$18.5K | ﹤0.01% | 449 |
|
|
2020
Q2 | $1.37M | Buy |
67,530
+16,912
| +33% | +$303K | ﹤0.01% | 428 |
|
|
2020
Q1 | $524K | Sell |
50,618
-373
| -0.7% | -$10.4K | ﹤0.01% | 494 |
|
|
2019
Q4 | $1.92M | Buy |
50,991
+14,155
| +38% | +$636K | ﹤0.01% | 457 |
|
|
2019
Q3 | $1.72M | Buy |
36,836
+709
| +2% | +$33K | ﹤0.01% | 470 |
|
|
2019
Q2 | $1.89M | Buy |
36,127
+8,355
| +30% | +$490K | ﹤0.01% | 472 |
|
|
2019
Q1 | $1.91M | Buy |
27,772
+2,824
| +11% | +$189K | ﹤0.01% | 509 |
|
|
2018
Q4 | $1.49M | Buy |
24,948
+1,004
| +4% | +$86.6K | ﹤0.01% | 526 |
|
|
2018
Q3 | $2.77M | Buy |
23,944
+13,140
| +122% | +$1.48M | 0.01% | 519 |
|
|
2018
Q2 | $1.36M | Buy |
10,804
+2,348
| +28% | +$286K | ﹤0.01% | 553 |
|
|
2018
Q1 | $915K | Buy |
8,456
+572
| +7% | +$63.3K | ﹤0.01% | 573 |
|
|
2017
Q4 | $864K | Buy |
7,884
+2,228
| +39% | +$222K | ﹤0.01% | 566 |
|
|
2017
Q3 | $558K | Buy |
5,656
+406
| +8% | +$39.4K | ﹤0.01% | 581 |
|
|
2017
Q2 | $532K | Buy |
5,250
+132
| +3% | +$14.2K | ﹤0.01% | 569 |
|
|
2017
Q1 | $591K | Buy |
5,118
+763
| +18% | +$88.7K | ﹤0.01% | 603 |
|
|
2016
Q4 | $523K | Buy |
4,355
+76
| +2% | +$8.41K | ﹤0.01% | 638 |
|
|
2016
Q3 | $481K | Buy |
4,279
+2,816
| +192% | +$324K | ﹤0.01% | 622 |
|
|
2016
Q2 | $182K | Buy |
1,463
+645
| +79% | +$77.9K | ﹤0.01% | 631 |
|
|
2016
Q1 | $92K | Buy |
818
+407
| +99% | +$42.3K | ﹤0.01% | 673 |
|
|
2015
Q4 | $45K | Buy |
+411
| New | +$47K | ﹤0.01% | 735 |
|
|
2015
Q1 | – | Sell |
-131,690
| Closed | -$15.8M | – | 735 |
|
|
2014
Q4 | $15.8M | Sell |
131,690
-2,414
| -2% | -$317K | 0.04% | 408 |
|
|
2014
Q3 | $19.6M | Buy |
134,104
+36,647
| +38% | +$5.66M | 0.06% | 323 |
|
|
2014
Q2 | $16.3M | Buy |
97,457
+24,786
| +34% | +$4.41M | 0.05% | 418 |
|
|
2014
Q1 | $14.4M | Buy |
72,671
+35
| +0% | +$6.61K | 0.04% | 441 |
|
|
2013
Q4 | $13.9M | Buy |
72,636
+3,514
| +5% | +$654K | 0.04% | 442 |
|
|
2013
Q3 | $11.7M | Buy |
69,122
+1,582
| +2% | +$246K | 0.04% | 468 |
|
|
2013
Q2 | $10.2K | Buy |
+67,540
| New | +$9.57M | 0.04% | 472 |
|
Other funds holding CLB
AI
FAM
BTW
DGI
